Dermatitis Herpetiformis
Recent clinical, regulatory, research and industry developments relating to this disease.
Dermatitis Herpetiformis: Novel Perspectives.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes2
- Dermatitis Herpetiformis1
- Diet, Gluten-Free1
Leading journals2
- Frontiers in immunology1
- United European gastroenterology journal1
Leading researchers8
- Al-Toma A1
- Antiga E1
- Auricchio R1
- Bonciani D1
- Bonciolini V1
- Caproni M1
- Castillejo G1
- Cellier C1
Affiliations (unnormalised)6
- Hospital Universitari Sant Joan de Reus1
- KG Jebsen Coeliac Disease Research Centre1
- Oslo University Hospital Rikshospitalet1
- Royal Hallamshire Hospital & University of Sheffield1
- St. Antonius Hospital1
- University of Bologna1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
Rare, chronic, papulo-vesicular disease characterized by an intensely pruritic eruption consisting of various combinations of symmetrical, erythematous, papular, vesicular, or bullous lesions. The disease is strongly associated with the presence of HLA-B8 and HLA-DR3 antigens. A variety of different autoantibodies has been detected in small numbers in patients with dermatitis herpetiformis.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.